Covestor LTD Acadia Pharmaceuticals Inc Transaction History
Covestor LTD
- $160 Million
- Q4 2024
A detailed history of Covestor LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Covestor LTD holds 844 shares of ACAD stock, worth $14,508. This represents 0.01% of its overall portfolio holdings.
Number of Shares
844
Previous 669
26.16%
Holding current value
$14,508
Previous $10,000
60.0%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$737 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$240 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$207 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$150 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$125 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.78B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...